Vanda Pharmaceuticals Announces Participation at September 2025 Investor Conferences
Vanda Pharmaceuticals (Nasdaq: VNDA) has announced its participation in three major healthcare investor conferences in September 2025. The company will present at the Cantor Global Healthcare Conference in New York on September 3 at 3:55 PM ET, the Wells Fargo Healthcare Conference in Boston on September 4 at 4:30 PM ET, and the H.C. Wainwright Annual Global Investment Conference in New York on September 9 at 8:30 AM ET.
All presentations will be accessible through live webcasts on Vanda's corporate website, with archived versions available for approximately 30 days following the events.
Vanda Pharmaceuticals (Nasdaq: VNDA) ha annunciato la sua partecipazione a tre importanti conferenze per investitori del settore sanitario a settembre 2025. L'azienda terr脿 presentazioni al Cantor Global Healthcare Conference a New York il 3 settembre alle 15:55 ET, al Wells Fargo Healthcare Conference a Boston il 4 settembre alle 16:30 ET e all'H.C. Wainwright Annual Global Investment Conference a New York il 9 settembre alle 08:30 ET.
Tutte le presentazioni saranno trasmesse in diretta via webcast sul sito aziendale di Vanda, con le registrazioni disponibili in archivio per circa 30 giorni dopo gli eventi.
Vanda Pharmaceuticals (Nasdaq: VNDA) ha anunciado su participaci贸n en tres importantes conferencias para inversores del sector sanitario en septiembre de 2025. La compa帽铆a realizar谩 presentaciones en el Cantor Global Healthcare Conference en Nueva York el 3 de septiembre a las 3:55 PM ET, en el Wells Fargo Healthcare Conference en Boston el 4 de septiembre a las 4:30 PM ET y en el H.C. Wainwright Annual Global Investment Conference en Nueva York el 9 de septiembre a las 8:30 AM ET.
Todas las presentaciones se podr谩n seguir por webcast en directo desde la web corporativa de Vanda, y las grabaciones quedar谩n disponibles en archivo durante aproximadamente 30 d铆as tras los eventos.
Vanda Pharmaceuticals (Nasdaq: VNDA)電� 2025雲� 9鞗旍棎 鞐措Μ電� 欤检殧 項姢旒�鞏� 韴瀽鞛� 須岇潣 靹� 瓿踌棎 彀戈皜頃滊嫟瓿� 氚滍憸頄堨姷雼堧嫟. 須岇偓電� 9鞗� 3鞚� 鞓れ爠 3鞁� 55攵�(ET)鞐� 雺挫殨鞐愳劀 鞐措Μ電� Cantor Global Healthcare Conference鞐愳劀, 9鞗� 4鞚� 鞓ろ泟 4鞁� 30攵�(ET)鞐� 氤挫姢韯挫棎靹� 鞐措Μ電� Wells Fargo Healthcare Conference鞐愳劀, 攴鸽Μ瓿� 9鞗� 9鞚� 鞓れ爠 8鞁� 30攵�(ET)鞐� 雺挫殨鞐愳劀 鞐措Μ電� H.C. Wainwright Annual Global Investment Conference鞐愳劀 氚滍憸頃� 鞓堨爼鞛呺媹雼�.
氇摖 氚滍憸電� Vanda鞚� 旮办梾 鞗轨偓鞚错姼毳� 韱淀暣 鞁れ嫓臧� 鞗轨簮鞀ろ姼搿� 鞁滌箔頃� 靾� 鞛堨溂氅�, 頄夓偓 膦呺 頉� 鞎� 30鞚缄皠 鞎勳勾鞚措笇搿� 鞝滉车霅╇媹雼�.
Vanda Pharmaceuticals (Nasdaq: VNDA) a annonc茅 sa participation 脿 trois grandes conf茅rences d茅di茅es aux investisseurs en sant茅 en septembre 2025. La soci茅t茅 pr茅sentera au Cantor Global Healthcare Conference 脿 New York le 3 septembre 脿 15h55 ET, au Wells Fargo Healthcare Conference 脿 Boston le 4 septembre 脿 16h30 ET, et au H.C. Wainwright Annual Global Investment Conference 脿 New York le 9 septembre 脿 08h30 ET.
Toutes les pr茅sentations seront diffus茅es en direct via webcast sur le site corporate de Vanda, les enregistrements restant accessibles en archive pendant environ 30 jours apr猫s les 茅v茅nements.
Vanda Pharmaceuticals (Nasdaq: VNDA) hat seine Teilnahme an drei bedeutenden Healthcare-Investorenkonferenzen im September 2025 angek眉ndigt. Das Unternehmen wird am Cantor Global Healthcare Conference in New York am 3. September um 15:55 Uhr ET, am Wells Fargo Healthcare Conference in Boston am 4. September um 16:30 Uhr ET sowie am H.C. Wainwright Annual Global Investment Conference in New York am 9. September um 08:30 Uhr ET pr盲sentieren.
Alle Pr盲sentationen werden live per Webcast auf der Unternehmenswebsite von Vanda 眉bertragen; Aufzeichnungen stehen etwa 30 Tage nach den Veranstaltungen im Archiv zur Verf眉gung.
- None.
- None.
The Cantor Global Healthcare Conference 2025 in
The 2025 Wells Fargo Healthcare Conference in
The H.C. Wainwright Annual Global Investment Conference in
The corporate presentations given at the Cantor, Wells Fargo and H.C. Wainwright conferences may be accessed live on Vanda's corporate website, . Investors should click on the Investors tab and follow the link under Recent Events. Investors are advised to go to the conference website at least 15 minutes early to register, download, and install any necessary software or presentations. A link to the archived conference will be available on Vanda's website for a period of approximately 30 days.
About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit 听and follow us on X @vandapharma.
Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
[email protected]
Jim Golden / Jack Kelleher / Dan Moore
Collected Strategies
[email protected]听
View original content to download multimedia:
SOURCE Vanda Pharmaceuticals Inc.
FAQ
When is Vanda Pharmaceuticals (VNDA) presenting at the Cantor Global Healthcare Conference 2025?
How can investors access Vanda Pharmaceuticals' (VNDA) September 2025 conference presentations?
Which investor conferences will Vanda Pharmaceuticals (VNDA) attend in September 2025?
What time is Vanda Pharmaceuticals' (VNDA) presentation at the Wells Fargo Healthcare Conference 2025?
